Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Cancer Research
|
July 30, 2011
Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer
Medha S Darshan, Matthew S Loftus, Maria Thadani-Mulero, et al.
Journal of the National Cancer Institute
|
December 25, 2012
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions
Jonathan L Vandergrift, Joyce C Niland, Richard L Theriault, et al.
Plos One
|
May 5, 2012
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device
Brian J Kirby, Mona Jodari, Matthew S Loftus, et al.
Cancer Medicine
|
September 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
James Sun, Xiaojun Zhong, Junjie Ma, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study
Kamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
Advances in Radiation Oncology
|
December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
Kamran A Ahmed, Youngchul Kim, John A Arrington, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2015
Breast Cancer Risk Reduction, Version 2.2015
Therese B Bevers, John H Ward, Banu K Arun, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Cancer Research
|
July 30, 2011
Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer
Medha S Darshan, Matthew S Loftus, Maria Thadani-Mulero, et al.
Journal of the National Cancer Institute
|
December 25, 2012
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions
Jonathan L Vandergrift, Joyce C Niland, Richard L Theriault, et al.
Plos One
|
May 5, 2012
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device
Brian J Kirby, Mona Jodari, Matthew S Loftus, et al.
Cancer Medicine
|
September 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
James Sun, Xiaojun Zhong, Junjie Ma, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study
Kamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
Advances in Radiation Oncology
|
December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
Kamran A Ahmed, Youngchul Kim, John A Arrington, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2015
Breast Cancer Risk Reduction, Version 2.2015
Therese B Bevers, John H Ward, Banu K Arun, et al.
Page
of 4